Navigation Links
Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
Date:10/14/2008

BOSTON, Oct. 14 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (OTC Pink Sheets: SNDY) is pleased to announce that the Company is in the final stages to upgrade its status on the Pinksheets Electronic OTC Markets from Limited Information to Current Information. The Company is in the process of completing their Issuer Information Statement, which will be accompanied by an attorney's opinion letter. The Company expects to have its status upgraded by the end of the quarter.

A Pinksheets status of current information indicates that Solos Endoscopy, Inc. will make its current information publicly available through the OTC Disclosure and News Service according to the Pink OTC Markets manual: Guidelines for Providing Adequate Current Information. There are currently 1,111 companies trading under current information as opposed to 521 companies trading under limited information. The 1,111 companies trading under current information represented approximately 65.4% of the total dollar volume traded during the month of December 2007, according to Pinksheets.com.

"By upgrading our status to current information, we are demonstrating to our shareholders that we are working hard to increase the value of our stock as we move forward with our business strategy over the next several months," stated Bob Segersten, President of Solos Endoscopy, Inc.

Please click on the link to view the Guidelines for Providing Adequate Current Information. (http://www.pinksheets.com/content/doc/ps/Disclosure/Guidelines/2.pdf)

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make
'/>"/>

SOURCE Solos Endoscopy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
2. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
3. Essilor Finalizes Satisloh Agreement
4. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
5. 2008 R&D Innovator of the Year & Scientist of the Year Finalists Announced
6. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
7. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
8. Prix Galien USA Announces 2008 Final Candidates
9. White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product
10. Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation
11. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Resilinc released online today ... which summarizes and analyzes nearly 700 unique supply chain ... 24X7 global event monitoring and alert reporting service. Supply ... trial period of the email service to receive early ... negatively impact revenue, market share, customer satisfaction, and shareholder ...
(Date:3/2/2015)... and VANCOUVER, British Columbia ... ("InMed") (CSE: IN; OTCQB: IMLFF), a clinical stage ... based therapies, today announced that Craig Schneider ... overview during a live webcast at VirtualInvestorConferences.com. ... LINK:   http://VirtualInvestorConferences.com > click the red ...
(Date:3/2/2015)... , March 2, 2015 Editor ... bottom.   Moments ago, Analysts Review released ... Sunshine Heart (NASDAQ: SSH ), Synergetics ... Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... Review provides a single unified platform for investors, to hear ...
(Date:3/2/2015)... 2015 Sterlitech is proud to debut ... at the 2015 AMTA Membrane Technology Conference in Orlando. ... decade’s worth of engineering and customer feedback, which has ... range of applications across an array of disciplines. ... the dynamic needs of researchers and engineers alike and ...
Breaking Biology Technology:Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3InMed Pharmaceuticals to Present Investor Webcast March 5 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Sterlitech Displays Complete CF042 Membrane Test System 2
... REGENSBURG, Germany, June 17 , ... the Field of Reproductive Medicine , - ... Exhibition in,Amsterdam (Stand 87/88) , The IT ... its new software for in vitro fertilisation, MedITEX IVF,at the 25th ...
... book by Advanced Cell Technology,s Chief Scientist, Robert Lanza yields ... June 16 MSNBC.com featured today Dr. Robert Lanza,s book ... and Consciousness are the Keys to Understanding the True Nature ... "Cosmic Log." The article by Science Editor Alan Boyle ...
... Center of Innovation To Commercialize NC,s Nanobio Ideas , ... The North Carolina Biotechnology Center has approved a four-year, ... Nanobiotechnology (COIN) to develop the commercial potential of nanobiotechnology ... , "Nanobiotechnology is an exciting new discipline that has ...
Cached Biology Technology:New IVF Software MedITEX to be Presented at the ESHRE Exhibition 2MSNBC Publishes Free Online Abridgment of 'Biocentrism' 2MSNBC Publishes Free Online Abridgment of 'Biocentrism' 3Nanobiotech Center Wins $2.5 Million, 4-Year Grant 2Nanobiotech Center Wins $2.5 Million, 4-Year Grant 3
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... image, processing technology to the difficult challenge of rapidly collecting ... ... Aware, Inc. (Nasdaq:,AWRE), a global provider of imaging and ... software,development kits used to perform rapid autocapture and compliance assurance,of ...
... Microscopic worms used for scientific research are living longer ... on how the human body ages and how doctors ... cause inherited diseases, according to a new University of ... study of its kind, researchers manipulated the metabolic state ...
... p.m. to 7:30 p.m. , The New York Academy ... 40th Floor, New York, NY 10007 The Malaria ... Public Health and The New York Academy of Sciences ... half-day symposium to highlight the latest research developments in ...
Cached Biology News:Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture 2Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture 3CU-Boulder worm study sheds light on human aging, inherited diseases 2CU-Boulder worm study sheds light on human aging, inherited diseases 3Progress Against Malaria: Developments on the Horizon 2
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
... Mucin 3 (MUC3) is a glycoprotein. ... a lesser extent in breast, lung and ... shows no cross-reaction with MUC1 and MUC2. ... human MUC3 Immunogen: MUC3 tandem ...
... bottoms,• Nonreversible lids with ... contamination,• Individual alphanumerical codes ... footprint for ease in ... cell attachment,• Sterilized by ...
Biology Products: